跳至主要内容
临床试验/NCT02800356
NCT02800356已完成不适用

Subthreshold Laser Treatment for Reticular Pseudodrusen and Incipient Geographic Atrophy Secondary to Age - Related Macular Degeneration: a Pilot Study

Ospedale San Raffaele2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2016年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
2
主要终点
Retinal Sensitivity

研究概览

简要总结

To evaluate the effectiveness of subthreshold laser treatment on retinal sensitivity in patients with reticular pseudodrusen and incipient Geographic Atrophy (GA) secondary to Age-Related Macular Degeneration (AMD). Secondary objective is to investigate changes in best-corrected visual acuity, atrophy progression and safety.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • GA < 0.5 disk areas secondary to AMD and/or Reticular pseudodrusen
  • 50 years or older
  • The periphery of the atrophic lesions must demonstrate increased autofluorescence
  • Best corrected visual acuity between 20/20 and 20/400 inclusive
  • Clear ocular media
  • Ability to provide informed consent and attend all study visits

排除标准

  • GA secondary to other causes aside from AMD
  • Evidence of choroidal neovascularization in either eye
  • Any prior treatment for AMD, aside from antioxidants
  • Any other ocular condition that would progress in the study period and confound visual acuity assessment
  • Any ocular or systemic medication known to be toxic to the lens, retina or optic nerve
  • Presence of idiopathic or autoimmune-associated uveitis
  • Any intraocular surgery 3 months of entry
  • Any prior thermal laser in the macula
  • History of vitrectomy, filtering surgery, corneal transplant or retinal detachment surgery
  • Previous therapeutic radiation in the ocular region in either eye
  • Any treatment with an investigational agent in the previous 60 days before study entry
  • Women of child-bearing potential, defined as all women less than 1 year postmenopausal or less than 6 weeks since sterilization at Baseline, unless they are using highly effective methods of contraception during dosing of study treatment
  • Participation in an investigational drug, biologic, or device study within 6 Months prior to Baseline [Note: observational clinical studies solely involving over-the-counter vitamins, supplements, or diets are not exclusionary

结局指标

主要结局

Retinal Sensitivity

时间窗: Baseline, 4 weeks and 12 weeks

Change in retinal sensitivity on customized microperimetry (treated area).

次要结局

  • Visual Acuity(Baseline, 4 weeks and 12 weeks)
  • The Thickness of the Outer Nuclear Layer in the Treated Area(Baseline, 4 weeks and 12 weeks)
  • Number of Partecipants With Adverse and Serious Adverse Events(4 weeks and 12 weeks)
  • Number of Partecipants With Presence of Haemorrhage, Photocoagulation Spots, Ischemic Areas(4 weeks and 12 weeks)
  • Intraocular Pressure(4 weeks and 12 weeks)

研究者

发起方
Ospedale San Raffaele
申办方类型
Other
责任方
Principal Investigator
主要研究者

Querques Giuseppe

Head-Medical retina & Imaging unit

Ospedale San Raffaele

研究点 (2)

Loading locations...

相似试验